Kanchana Ravichandran, Erwan LeScolan, Na Cai, Bruce Howng, Robert Lau, Lisa Clark, Joshua Millet, Pankaj Kumar, Sushma Gurumurthy, Raghava Sriramaneni, Sean McAllister, Vangipuran Rangan, Olga Vasiljeva, Madan Paidhungat, Dylan Daniel, Marcia Belvin, Lin Guey. Presented at the American Association for Cancer Research Annual Meeting, April 28, 2025.
Learn MoreBenjamin Povinelli, Kamaljeet Kaur, Alexey Berezhnoy, Hsin Wang, Na Cai, Nicole Lapuyade, Carol LePage, Michael Winter, Olga Vasiljeva, Madan Paidhungat, Vangipuram Rangan, Erwan Le Scolan, Leila Boustany, Marcia Belvin and Dylan Daniel. Presented at SITC 2023, November 1-5, 2023, San Diego, CA.
Learn MoreMarcia Belvin Ph.D. Presented at World ADC, October 16-19, 2023, San Diego, California.
Learn MoreDylan Daniel, Ph.D., Presented at the American Association of Immunologists Annual Meeting, May 13, 2023.
Learn MoreKathy Miller, Sara M. Tolaney, Leisha Emens, Sung-Bae Kim, Erika Hamilton, Cristina Saura, Lucia Sanz, Valentina Boni, Filipa Lynce, Juan M. Cejalvo, Jennifer A. Crozier, Shirley Wang, Shannon Tsai, Hojjat Bazzazi, Hirdesh Uppal, Alison Hannah, Sara Hurvitz. Poster presented at the San Antonio Breast Cancer Symposium®, December 6-10, 2022.
Learn MoreAlexey Berezhnoy, Ph.D., Presented at the Society for Immunotherapy of Cancer’s 37th Annual Meeting (SITC 2022), November, 8th, 2022.
Learn MoreMarcia Belvin, SVP, Head of Research
Learn MoreAlexey Berezhnoy, Ph.D., Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, April 11th, 2022.
Learn MoreBoni V, Fidler MJ, Arkenau HT, et al. Praluzatamab ravtansine, a CD166-targeting antibody-drug conjugate, in patients with advanced solid tumors: an open-label phase 1/2 trial [published online ahead of print, 2022 Feb 14]. Clin Cancer Res. 2022;clincanres.3656.2021. doi:10.1158/1078-0432.CCR-21-3656
Learn MoreAlexey Berezhnoy, Ph.D., Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021), November 13th, 2021.
Learn More